Discussion In this large population-based study of individuals with NAFLD and type 2 diabetes, three major CVEs and mortality rate were compared between patients treated with and without GLP-1RAs treatment

Disclosures: Mohammad AbuAssi: Nothing to Disclose, Dara Suleiman: Nothing to Disclose, Saqr Alsakarneh: Nothing to Disclose, Farah Khraisat: Nothing to Disclose, Talib Al-Abcha: Nothing to Disclose, Harsimran Kalsi: Nothing to Disclose, Tony Brar: Nothing to Disclose, Yaseen Perbtani: Nothing to Disclose 1304 HIGH-THROUGHPUT PROTEOMICS ANALYSIS IDENTIFIES CHANGES IN CIRCULATING PROTEOME SIGNATURES ACROSS DIFFERENT STAGES OF LIVER TRANSPLANTATION SURGERY Xing Li 1 Emily Bethea 1 Leigh Anne Dageforde 1 Katherine Specht 1 Russell Goodman 1 , 1 Massachusetts General Hospital Background: Circulating proteomics, the unbiased global analysis of quantitative protein expression, has been applied to identify the diagnostic and pathophysiologic signatures of various liver diseases such as ALD, MASLD and HCC
GLP-1 agonists are contraindicated in pregnancy and breastfeeding
The images from immunostaining were exported as Leica image files and were processed using LASX software